KATHETERANORDNUNG

Patent europeic · EP3697344 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3697344
Numer da la dumonda
EP18792665
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
28-09-2018
Publitgà
26-08-2020
Concedì
24-06-2026
La protecziun finescha il pli tard
27-09-2038
Proxima taxa annuala scadenta
30-09-2026
Classas IPC
A61F 2/24 (2006.01)
Prioritad
US 201762573883 P 18.10.2017
Dumonda PCT
PCT/US2018/053532 28.09.2018
Publicaziun PCT
WO2019/079019 25.04.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-06-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 24.06.2026

Partidas

Possessur

Edwards Lifesciences Corporation

One Edwards Way, Irvine, CA 92614, US

Inventur

VALDEZ, Michael, G.

Irvine CA 92614, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.